Chandler Park (English Wikipedia)

"Castle Connolly Top Doctor in 2020". www.americanregistry.com. Retrieved April 9, 2021.
"Castle Connolly Top Doctor in 2021". www.americanregistry.com. Retrieved April 9, 2021.
"Patients Choice Award". www.americanregistry.com. Retrieved April 6, 2021.
"Compassionate Doctor Award". www.americanregistry.com. Retrieved April 6, 2021.
"Kentucky's Favorite Doctors". www.americanregistry.com. Retrieved April 6, 2021.
"Top 1% of Doctors". www.americanregistry.com. Retrieved April 6, 2021.

amjorthopedics.com

"Nicotine on bone blood flow". American Journal of Orthopedics. Archived from the original on August 15, 2016. Retrieved June 29, 2016.

asco.org

mocapp.asco.org

"ASCO Faculty. Cme Information January 2018 1 » MOC". mocapp.asco.org. Retrieved April 6, 2021.
"ASCO Faculty Cme Info 2019 Breast And Gynecologic Cancers » MOC". mocapp.asco.org. Retrieved April 6, 2021.
"Faculty Cme Info 2019 Anticancer Therapeutics Research And Supportive Care » MOC". mocapp.asco.org. Retrieved April 6, 2021.
"ASCO Faculty Cme Info 2020 Self Evaluation App Hematologic Malignancies » MOC". mocapp.asco.org. Retrieved April 6, 2021.

meetinglibrary.asco.org

"PET/CT and regional brain metabolic changes associated with depression in metastatic breast cancer. (presented at 2016 ASCO Annual Meeting)". ASCO University. Retrieved July 3, 2016.
"Pemetrexed and Non Small Cell Lung Cancer at 2015 American Society of Clinical Oncology Research Papers". asco.org.
"Metformin use and allogeneic stem cell transplant (ASCT) outcomes at 2015 American Society of Clinical Oncology Meeting". asco.org.

ascopubs.org

Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021). "Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)". Journal of Clinical Oncology. 39 (18_suppl): LBA4. doi:10.1200/JCO.2021.39.15_suppl.LBA4. ISSN 0732-183X. S2CID 236400202.

cancervisit.com

"Cancervisit". cancervisit.com. Retrieved July 3, 2016.

castleconnolly.com

"Search Top Doctors. Find Trusted Care". Castle Connolly. Retrieved April 9, 2021.
"Dr. Chandler H. Park - Medical Oncology - Castle Connolly Top Doctor". Castle Connolly. Retrieved April 6, 2021.

css.edu

"Med school requirements every healthcare hopeful should master in college". Retrieved May 3, 2017.

curetoday.com

"Advice for Patients with Advanced Renal Cell Carcinoma". Curetoday. October 25, 2023. Retrieved December 23, 2023.
"Combination Immunotherapy for Treating Advanced Renal Cell Carcinoma". Curetoday. October 18, 2023. Retrieved December 23, 2023.

doi.org

Sartor, Oliver; Bono, Johann de; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal of Medicine. 385 (12): 1091–1103. doi:10.1056/NEJMoa2107322. PMC 8446332. PMID 34161051.
Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021). "Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)". Journal of Clinical Oncology. 39 (18_suppl): LBA4. doi:10.1200/JCO.2021.39.15_suppl.LBA4. ISSN 0732-183X. S2CID 236400202.
Park, Chandler; Perini, Jessica; Farmer, Roger W; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Expert Review Medical Journal: Sorafenib and Thyroid Cancer". Expert Review of Endocrinology & Metabolism. 9 (6): 561–570. doi:10.1586/17446651.2014.960391. PMID 30736194. S2CID 56683794.

doximity.com

opmed.doximity.com

"Chandler Park, MD, FACP". opmed.doximity.com. Retrieved October 5, 2019.
"Doximity Op-(m)ed". n.d.
Park, Chandler (August 29, 2017). "How to Avoid being labeled a Problem Resident". opmed.doximity.com. Retrieved August 29, 2017.
Park, Chandler (December 13, 2017). "Practice-Changing Update for Newly Diagnosed Stage III or Stage IV Hodgkin's Lymphoma Patients". doximity.com. Retrieved December 13, 2017.
"ASH 2018: Research That Will Make a Difference for Tomorrow's Oncologist". opmed.doximity.com. Retrieved January 5, 2019.
"2020 Kidney Cancer Update with Dr. Toni Choueiri at ESMO". opmed.doximity.com. Retrieved April 9, 2021.
"2020 Prostate Cancer Update with Dr. Neeraj Agarwal". opmed.doximity.com. Retrieved April 9, 2021.
"2020 Bladder Cancer Review with Dr. Petros Grivas: What Every Physician Should Know". opmed.doximity.com. Retrieved April 9, 2021.

doximity.com

"Doximity". doximity.com. Retrieved January 5, 2019.

blog.doximity.com

Park, Chandler (June 3, 2017). "Breaking News Coverage from ASCO". doximity.com. Retrieved June 3, 2017.

eventscribe.com

Park, Chandler (January 22, 2018). "Designing CPD That Improves Patient Care: Insights From a Practicing Oncologist". eventscribe.com. Retrieved January 22, 2018.
"2020 Alliance Annual Conference". www.eventscribe.com. Retrieved April 6, 2021.

imdb.com

"Chandler Park". IMDb. Retrieved April 6, 2021.

louisville.edu

"Joint, Associate, & Adjunct Faculty — School of Medicine University of Louisville". louisville.edu. Retrieved April 6, 2021.
"Advisory Deans — School of Medicine University of Louisville". louisville.edu. Retrieved April 6, 2021.

managedhealthcareexecutive.com

"Developments in CAR T". Managed Healthcare Executive. Retrieved April 6, 2021.
Rowh, Mark (July 2, 2018). "Five Ways Health Execs Can Improve Lymphoma Treatment". managedhealthcareexecutive.com/non-hodgkin-lymphoma/five-ways-health-execs-can-improve-lymphoma-treatment. Retrieved July 2, 2018.

medscape.com

Skwarecki, Beth (February 10, 2017). "Unmatched after match day – What's Next?". Medscape. Retrieved February 10, 2017.
Skwarecki, Beth (February 10, 2017). "Unmatched After Match Day – What's Next?". medscape.com.

mhmedical.com

hemonc.mhmedical.com

"Authors | Lung Cancer: Standards of Care | AccessHemOnc | McGraw-Hill Medical". hemonc.mhmedical.com. Retrieved April 6, 2021.

muckrack.com

"Chandler Park | Freelance Journalist | Muck Rack". muckrack.com. Retrieved April 6, 2021.

neurology.org

Adcock, Amelia; Park, Chandler; Gyure, Kymberly; Bittner, Frank; Murray, Ann (April 6, 2015). "Atypical Neurolymphomatosis: How to treat". Neurology. 84 (14 Supplement): 2.012.

newsweek.com

"Budget cuts could lead to more radon deaths". Newsweek. April 30, 2017. Retrieved May 3, 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sartor, Oliver; Bono, Johann de; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal of Medicine. 385 (12): 1091–1103. doi:10.1056/NEJMoa2107322. PMC 8446332. PMID 34161051.
Park, Chandler; Perini, Jessica; Farmer, Roger W; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Expert Review Medical Journal: Sorafenib and Thyroid Cancer". Expert Review of Endocrinology & Metabolism. 9 (6): 561–570. doi:10.1586/17446651.2014.960391. PMID 30736194. S2CID 56683794.

ncbi.nlm.nih.gov

Sartor, Oliver; Bono, Johann de; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal of Medicine. 385 (12): 1091–1103. doi:10.1056/NEJMoa2107322. PMC 8446332. PMID 34161051.

onclive.com

"Dr. Park on the Increasing Use of Biomarker Testing and Radiotheranostics in Prostate Cancer". OncLive. March 6, 2023. Retrieved December 23, 2023.
"AR Pathway Inhibitors, ADCs, and IO/TKI Combinations Shape Standard Therapy in GU Cancers". OncLive. February 24, 2023. Retrieved December 23, 2023.
"Dr Park on Navigating of Later-line Treatment Options in Metastatic Urothelial Carcinoma". OncLive. May 9, 2023. Retrieved December 23, 2023.

patientcomfortsystems.com

"Study Shows Patient Comfort Systems MRI Pads Reduce Patient Motion and Exam Call-Backs : Innovative New TEMPUR Material (Developed by Tempur-Pedic Inc.) Enhances Patient Comfort According to Study to be Presented at RSNA 06" (PDF). Patientcomfortsystems.com.

rd.com

"Myths About What Cancer Is and Cancer Causes | Reader's Digest". Reader's Digest. Retrieved May 3, 2017.
Andersen, Charlotte (August 12, 2017). "50 Things Your Doctor Wishes You Knew About Losing Weight". rd.com. Retrieved August 12, 2017.
Hilton, Charlotte; ersenDec 18. "Things You Can Do Today to Lose Weight". Reader's Digest. Retrieved January 5, 2019.{{cite web}}: CS1 maint: numeric names: authors list (link)

rsna.org

archive.rsna.org

"MRI Viscoelastic Pads Presentation". RSNA.org.

semanticscholar.org

api.semanticscholar.org

Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021). "Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)". Journal of Clinical Oncology. 39 (18_suppl): LBA4. doi:10.1200/JCO.2021.39.15_suppl.LBA4. ISSN 0732-183X. S2CID 236400202.
Park, Chandler; Perini, Jessica; Farmer, Roger W; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Expert Review Medical Journal: Sorafenib and Thyroid Cancer". Expert Review of Endocrinology & Metabolism. 9 (6): 561–570. doi:10.1586/17446651.2014.960391. PMID 30736194. S2CID 56683794.

sitcancer.org

"Advances in Cancer Immunotherapy | Louisville". www.sitcancer.org. Retrieved April 9, 2021.

tandfonline.com

"Hospital Practice". tandfonline.com. Retrieved May 3, 2017.
"Hospital Practice Editorial Board". www.tandfonline.com. Retrieved April 6, 2021.

targetedonc.com

"Park Discusses Targeted Therapy Trials in Intermediate- and High-Risk ccRCC". Targeted Oncology. Retrieved April 6, 2021.
"Recent Trial Updates in Advanced Renal Cell Carcinoma (RCC)". Targeted Oncology. March 31, 2023. Retrieved December 23, 2023.
"Adjuvant Pembrolizumab in Patients with Clear-cell Renal Cell Carcinoma". Targeted Oncology. March 3, 2023. Retrieved December 23, 2023.

theet.com

Murray, Brittany. "Cancer Prevention Month celebrated with decreased cancer rates". The Exponent Telegram. Retrieved May 3, 2017.
Murray, Brittany (February 16, 2015). "Cancer Prevention Month celebrated with decreased cancer rates". The Exponent-Telegram. Retrieved January 22, 2017.

thefreelibrary.com

"RSNA smorgasbord a delight. – Free Online Library". Thefreelibrary.com.

threebestrated.com

"3 Best Oncologists in Louisville, KY - Expert Recommendations". ThreeBestRated.com. Retrieved April 9, 2021.

uky.edu

ukhealthcare.uky.edu

"Molecular Tumor Board". UK HealthCare. Retrieved December 23, 2023.
University of Kentucky, Markey Cancer Center (n.d.). "Markey's Molecular Tumor Board thriving in its first year". ukhealthcare.uky.edu. Retrieved May 3, 2017.

urologytimes.com

"Dr. Park on the ARASENS and TITAN trials in mHSPC". Urology Times. April 14, 2023. Retrieved December 23, 2023.

usnews.com

health.usnews.com

"Dr. Chandler Park at U.S. News & World Report". health.usnews.com. n.d. Retrieved July 3, 2016.
"Verification of Board Certifications". n.d.

usnews.com

Kowarski, Ilana (January 4, 2017). "5 Things to do before applying to medical school". U.S. News & World Report. Retrieved January 22, 2017.

web.archive.org

"Nicotine on bone blood flow". American Journal of Orthopedics. Archived from the original on August 15, 2016. Retrieved June 29, 2016.

wildapricot.org

kaomo.wildapricot.org

"Kentucky Society of Clinical Oncology Board of Trustees". kaomo.wildapricot.org. Retrieved August 15, 2020.

worldcat.org

search.worldcat.org

Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021). "Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)". Journal of Clinical Oncology. 39 (18_suppl): LBA4. doi:10.1200/JCO.2021.39.15_suppl.LBA4. ISSN 0732-183X. S2CID 236400202.

youtube.com

Doximity Physician Spotlight: Dr. Chandler Park, retrieved April 6, 2021